Novel cyclic peptides facilitating transcellular blood-brain barrier transport of macromolecules in vitro and in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel cyclic peptides facilitating transcellular blood-brain barrier transport of macromolecules in vitro and in vivo

Published:2020-05 Issue: Volume:321 Page:744-755
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Yamaguchi Shunsuke,Ito Shingo,Masuda Takeshi,Couraud Pierre-Olivier,Ohtsuki Sumio^ORCID

Funder

Japan Society for the Promotion of Science

Mochida Memorial Foundation for Medical and Pharmaceutical Research

Japan Agency for Medical Research and Development

Japan Science and Technology Agency

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference70 articles.

1. Immune checkpoint inhibitors of PD-L1 as cancer therapeutics;Akinleye;J. Hematol. Oncol.,2019

2. Peptide-based vaccination for antibody responses against HIV;Combadiere;Vaccines (Basel),2019

3. Lipid delivery systems for nucleic-acid-based-drugs: from production to clinical applications;Barba;Pharmaceutics,2019

4. Why is the global CNS pharmaceutical market so under-penetrated?;Pardridge;Drug Discov. Today,2002

5. The blood-brain barrier: bottleneck in brain drug development;Pardridge;NeuroRx.,2005

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug delivery pathways to the central nervous system via the brain glymphatic system circumventing the blood‐brain barrier;Exploration;2024-07-09

2. Angiopep-2-Functionalized Lipid Cubosomes for Blood–Brain Barrier Crossing and Glioblastoma Treatment;ACS Applied Materials & Interfaces;2024-02-28

3. Impact of P-Glycoprotein-Mediated Drug-Endogenous Substrate Interactions on Androgen and Blood-Brain Barrier Permeability;Journal of Pharmaceutical Sciences;2024-01

4. Unlocking novel therapies: cyclic peptide design for amyloidogenic targets through synergies of experiments, simulations, and machine learning;Chemical Communications;2024

5. Revolutionizing cancer treatment: The power of cell-based drug delivery systems;Journal of Controlled Release;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3